Tillkännagivande • May 25
Akanda Corp. Announces Receipt of Nasdaq Non-Compliance Letter Akanda Corp. announced that the Company is not in compliance with the periodic filing requirements for continued listing set in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission by the required due date. The Company intends to file the Form 20-F as soon as practicable. The Company is required to submit a plan, by July 19, 2026, which outlines the steps the Company expects to take to regain compliance. If Nasdaq accepts the Company's plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of the Form 20-F, or until November 16, 2026, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. The Nasdaq Notice has no immediate effect on the listing or trading of the Company's common shares, though Nasdaq makes available to investors a list of non-compliant companies, which will include Akanda beginning on approximately May 28, 2026. As part of this process, an indicator reflecting the Company's non-compliance will be broadcast over Nasdaq's market data dissemination network and will also be made available to third party market data providers. If the Company fails to timely regain compliance, the Company's common shares will be subject to delisting from Nasdaq. Tillkännagivande • May 03
Akanda Corp. announced delayed 20-F filing On 05/01/2026, Akanda Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC. Tillkännagivande • Jan 24
Akanda Corp. announced that it has received $7 million in funding On January 23, 2026, Akanda Corp. closed the transaction. The transaction involved institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7,000,000 in a private placement transaction. The company intends to pay the placement agent $70,000 in cash fees in relation to the offering at the closing. Tillkännagivande • Jan 20
Akanda Corp. announced that it expects to receive $7 million in funding Akanda Corp. entered into a securities purchase agreement with certain institutional investors for issuance of convertible promissory note for aggregate gross proceeds of $7,000,000 on January 20, 2026. The closing of the offering is expected to occur, subject to customary closing conditions, on January 21, 2026. The maturity date of each Note is the 12-month anniversary of the issuance date of such Note, and is the date upon which the principal amount, as well as any other fees, shall be due and payable. The Notes bear interest at a rate of 10% per annum. The Company is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act. Tillkännagivande • Apr 17
Akanda Corp., Annual General Meeting, Apr 30, 2025 Akanda Corp., Annual General Meeting, Apr 30, 2025. Location: gowling wlg (canada) llp, suite 1600, 100 king street, west, toronto, on, m5x 1g5, meeting id: 810 7467 7663, Canada Tillkännagivande • Oct 03
Akanda Corp. has completed a Follow-on Equity Offering in the amount of $1.5 million. Akanda Corp. has completed a Follow-on Equity Offering in the amount of $1.5 million.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 258,940
Price\Range: $1
Discount Per Security: $0.025
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Securities Offered: 1,241,060
Price\Range: $0.9999
Discount Per Security: $0.025 Tillkännagivande • Sep 05
Akanda Corp. has filed a Follow-on Equity Offering in the amount of $1.5 million. Akanda Corp. has filed a Follow-on Equity Offering in the amount of $1.5 million.
Security Name: Common Shares
Security Type: Common Stock
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant Board Change • Jul 30
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Interim CEO & Executive Director Katie Field is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Tillkännagivande • May 02
Akanda Corp. announced delayed 20-F filing On 04/30/2024, Akanda Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC. Tillkännagivande • Apr 27
Akanda Corp. Announces Board Changes Akanda Corp. announced the appointment of Christopher Cooper to its board of directors following the resignation of Harvinder Singh as a director. Mr. Christopher Cooper has over 20 years of extensive business experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. His experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Mr. Cooper has been a director of several private and public Company's over the last 20 years. Most recently he was a member of the board of directors of Alpha Lithium Corporation which was acquired by Tecpetrol in October 2023 for approximately CAD 313 million. Mr. Cooper was also a director of Counterpath Corporation, a Nasdaq listed company which was taken over by Alianza Inc. in March 2021 for USD 25.6 million. He received his Bachelor of Business Administration from Hofstra University and his Master's in Business Administration from Dowling College in New York. Tillkännagivande • Mar 23
Akanda Corp., Annual General Meeting, Mar 23, 2024 Akanda Corp., Annual General Meeting, Mar 23, 2024. Agenda: To consider a proposal to elect four directors to serve until the next meeting of shareholders at which the election of directors is considered, or until his or her successor is duly elected or appointed, unless he or she resigns, is removed or becomes disqualified in accordance with the articles of the Company or the Business Corporations Act. The nominees, Harvinder Singh, Jatinder Dhaliwal, David Jenkins and Katharyn Field, were elected to serve as directors; to consider a proposal to re-appoint GreenGrowth CPAs, as auditors of the Company for the 2024 fiscal year, and to authorize the audit committee of the Company to fix the auditors' remuneration and the terms of their engagement; and to consider other matters. Tillkännagivande • Mar 01
Akanda Corp. has filed a Follow-on Equity Offering in the amount of $0.149903 million. Akanda Corp. has filed a Follow-on Equity Offering in the amount of $0.149903 million.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 367,870
Price\Range: $0.20544
Discount Per Security: $0.00136
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Securities Offered: 361,972
Price\Range: $0.20534
Discount Per Security: $0.00138
Transaction Features: Registered Direct Offering Tillkännagivande • Feb 21
Akanda Corp. has filed a Follow-on Equity Offering in the amount of $5 million. Akanda Corp. has filed a Follow-on Equity Offering in the amount of $5 million.
Security Name: Common Shares
Security Type: Common Stock
Security Name: Warrants
Security Type: Equity Warrant
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant Tillkännagivande • Feb 03
SOMAI Pharmaceuticals Inc. entered into Non-Binding Letter of Intent to acquire Rpk Biopharma, Unipessoal, Lda from Akanda Corp. (NasdaqCM:AKAN). SOMAI Pharmaceuticals Inc. entered into Non-Binding Letter of Intent to acquire Rpk Biopharma, Unipessoal, Lda from Akanda Corp. (NasdaqCM:AKAN) on February 2, 2024. Transaction is subject to customary due diligence, representations and warranties, covenants, indemnities and closing conditions. Tillkännagivande • Dec 12
Akanda Corp. Appoints Charn Deol as Chief Financial Officer Akanda Corp. reported that it has appointed a new Chief Financial Officer. Effective immediately Charn Deol will join the Company and come to Akanda with more than 35 years of financial markets. The Board replaced on December 4th 2023, the current CFO with Charn Deol, a multi-industry executive with over 35 years of public company management experience. Mr. Deol's recent experience includes being a director or in management of numerous Canadian private and public companies including CEO of Bayridge Resources Inc., a director of Amber Brands Inc., Green Battery Minerals Inc., and Neotech Metals Inc. He has been involved in initial IPOs being established which required taking private companies in Canada through the regulatory process of going public. New Risk • Nov 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Market cap is less than US$10m (€1.52m market cap, or US$1.66m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Revenue is less than US$5m (US$2.6m revenue). Tillkännagivande • Jul 07
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Akanda Corp. ("Akanda" or the “Company”) announced that the Company has received a written notification (the “Notification Letter”) on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that the closing bid price of the Company's common shares, no par value ("Common Shares"), was below $1.00 per share for a period of 30 consecutive business days. The Notification Letter does not impact the Company’s listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until January 1, 2024, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company’s common shares must have a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by January 1, 2024 the Company may be eligible for additional time to regain compliance or may face delisting. The Company’s business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its Common Shares and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its Common Shares to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. Reported Earnings • May 03
Full year 2022 earnings released: US$0.28 loss per share (vs US$5.01 loss in FY 2021) Full year 2022 results: US$0.28 loss per share. Net loss: US$8.24m (loss widened 1.3% from FY 2021). Tillkännagivande • Feb 17
Akanda Corp. Announces Board Changes On February 13th, 2023, the Board of Directors of Akanda Corp. also met to approve the appointment of David Jenkins as a Director of the company. Mr. Jenkins will be replacing Yuying Liang, who informed the company that she will be resigning as a Director, effective once Mr. Jenkins’ appointment to the Board of Directors has been finalized. Mr. Jenkins is a global financier with an extensive network of high net-worth investors. He has experience in public markets and has secured millions of dollars in capital for the mining industry. Mr. Jenkins currently serves as an independent director for Levitee Labs Inc. He holds a position as an independent director at Boundary Gold and Copper Mining LTD., as well as with Quantum Battery Metals Corp., and with Montego Resources. Tillkännagivande • Dec 23
Akanda Corp. Announces That Chief Executive Officer Tej Virk Has Been on A Paid Leave of Absence Both Administrative and Personal Since November 30, 2022 Akanda Corp. announced that Chief Executive Officer Tej Virk has been on a paid leave of absence both administrative and personal since November 30, 2022, pending an independent investigation being conducted by Canmart Directors and counsel. During his leave, Mr. Virk is not expected to perform any responsibilities as the Chief Executive Officer of the Company or any responsibilities as an officer of any of the Company’s subsidiaries. Tillkännagivande • Dec 22
Akanda Corp. Appoints Katie Field as an Executive Director Akanda Corp. appointed Katie Field, one of the Company’s Directors, as an Executive Director. Together with the other Directors, Ms. Field will provide interim management and the Company will continue to serve its customers, employees, and shareholders. Board Change • Nov 16
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. No experienced directors. No highly experienced directors. CEO & Director Tej Virk is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Tillkännagivande • Nov 02
Akanda Corp. Announces Resignation of Dr. Aslihan Akkar-Schenki as President the Company Dr. Aslihan Akkar-Schenki tendered her resignation, effective October 31, 2022, as President of Akanda Corp. to pursue other business opportunities and not due to any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. Tillkännagivande • Oct 05
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Akanda Corp. announced that the Company has received a written notification on September 27, 2022 from the Listing Qualifications Department of the Nasdaq Stock Market LLC, notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that the closing bid price of the Company's common shares, no par value ('Common Shares'), was below $1.00 per share for a period of 30 consecutive business days. The Notification Letter does not impact the Company's listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(3)(A), the Company has been provided 180 calendar days, or until March 27, 2023, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company's common shares must have a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by March 27, 2023, the Company may be eligible for additional time to regain compliance or may face delisting. The Company's business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its Common Shares and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its Common Shares to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. Tillkännagivande • Sep 09
Terry Booth Joins Akanda Corp. as Chair of Advisory Board Akanda Corp. (‘Akanda’ or the ‘company’) announced that Terry Booth, the founder of Aurora Cannabis Inc. (‘Aurora Cannabis’) has joined Akanda as a Chair of Akanda’s newly formed Advisory Board. Terry Booth was an original founder of Aurora Cannabis. He has a deep knowledge of highly regulated environments and has assembled and led diverse and highly-skilled team of experts from a broad range of disciplines to execute global cannabis business strategies. He has successfully made and integrated over 30 acquisitions and transactions in the last five years and has served as President/CEO of six other highly successful companies, such as Superior Safety Codes. Tillkännagivande • Aug 25
Akanda Corp. Appoints Tom Flow as Chief Operating Officer, Effective September 1, 2022 Akanda Corp. announced that it has appointed Tom Flow to the role of Chief Operating Officer of Akanda and Managing Director of Holigen, effective September 1, 2022. The Company believes that these two hires will enhance its leadership direction and boost profitability across the European medical cannabis market. Mr. Flow is an accomplished global business leader with over 15 years of direct cannabis industry experience with an emphasis on facility design and operations, including multiple large scale EU GMP certified cultivation facilities. He is the co-founder of a number of cannabis companies during this time, namely MedReleaf Corp. which was subsequently sold to Aurora Cannabis, The Flowr Corporation (“Flowr”) where he held executive roles including CEO, COO, President and Managing Partner, and Holigen Limited which the Company acquired from Flowr in May 2022. Both Mr. Flow and Mr. George will be based in offices at Akanda’s indoor premium cultivation facility in Sintra, Portugal. Tillkännagivande • Jul 27
Akanda Corp. Announces Resignation of Mohsen Rahimi as Member of the Board, Effective July 25, 2022 On July 22, 2022, Mohsen Rahimi notified the board of directors of Akanda Corp. that he intends to resign as a member of the Board, effective July 25, 2022. Mr. Rahimi’s decision to resign was not the result of any disagreement with the Company, any matter related to the Company’s operations, policies or practices, the Company’s management, or the Company’s Board. Effective July 25, 2022, the Board appointed Yuying Liang as a member of the Board to fill the vacancy on the Board that was created as a result of Mr. Rahimi’s resignation. Ms. Liang, age 32, has served as a Principal at Canmore Financial Services Inc., a company that provides accounting and financial reporting services to public companies, since January 2019. From August 2014 to November 2018, Ms. Liang served as a Senior Accountant at Jackson & Company, a full-service financial accounting firm that provides audit and accounting, taxation and management consulting services to middle market entrepreneurial businesses. Ms. Liang currently serves on the board of directors of Montego Resources Inc., a junior mineral exploration company engaged in the business of acquiring, exploring, and evaluating natural resource properties, Modern Plant Based Foods Inc., a Canadian food company based in Vancouver, British Columbia that offers a portfolio of plant-based products including meat and dairy-free alternatives, soups and vegan snacks, and Ultra Brands Ltd., a Canada-based agriculture-food holdings company that is focused on products and technologies in the food services industry. Ms. Liang was also previously a member of the board of directors of Boundary Gold and Copper Mining Ltd. and Essex Minerals Inc. Tillkännagivande • Jun 10
Akanda Corp., Annual General Meeting, Jun 24, 2022 Akanda Corp., Annual General Meeting, Jun 24, 2022, at 11:00 Eastern Daylight. Agenda: To receive the audited consolidated financial statements of the Corporation for the year ended December 31, 2021, together with the auditors' report thereon; to elect the directors of the Corporation for the ensuing year; to reappoint BF Borgers CPA PC as the auditors of the Corporation for the ensuing year and to authorize the board of directors of the Corporation (the "Board") to fix their remuneration and terms of engagement; and to transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof. Board Change • May 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO & Director Tej Virk is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. 